Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2025 (ended Mar 31, 2025): JPY 21.6887T (+6.2%) | Operating Profit: JPY 1.2134T (-12.2%) | FY2024: JPY 20.4286T (+20.8%) | Q3 FY2024 (9 months): Op Profit JPY 1.1399T, margin 7.0% | Auto sales down 297k (Asia impact) | FY2026 guidance: Net profit JPY 250B (-70.1%), Revenue JPY 20.3T (-6.4%)
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded into automobiles, power equipment, marine engines, and aerospace, becoming one of the largest and most diversified mobility companies in the world. With over 90 million vehicles sold globally and a reputation built on engineering reliability, fuel efficiency, and innovation, Honda operates manufacturing facilities across more than 30 countries on six continents.\n\nHonda's automotive lineup ranges from mass-market sedans and SUVs — including the best-selling Civic and CR-V — to trucks, minivans, and the premium Acura brand. The company is executing a major pivot to electrification through the Honda 0 Series, a new EV architecture designed from the ground up for battery-electric vehicles launching in 2026. Honda's partnership with General Motors on battery technology, combined with its investment in solid-state battery development, reflects a multi-path electrification strategy designed to hedge technology risk while building scale.\n\nHonda reported FY2025 revenue of JPY 21.7 trillion, a 6.2% year-over-year increase, driven by strong North American demand and favorable currency tailwinds. The company faces intensifying competition from Chinese EV manufacturers in Asia and is exploring a potential merger with Nissan as part of broader Japanese automotive consolidation. Honda's engineering culture, global manufacturing scale, and brand credibility in reliability position it as a resilient and well-capitalized incumbent navigating the EV transition.
Largest US pharmacy chain with ~9,000 locations. Expanding pharmacy-only format in 2026; parent CVS Health also operates Aetna and Caremark.
CVS Pharmacy is the largest pharmacy chain in the United States, operating approximately 9,000 retail pharmacy locations nationwide. Founded in 1963 and headquartered in Woonsocket, Rhode Island, CVS has grown from a regional drugstore chain into a healthcare mega-platform through decades of acquisitions and vertical integration. The retail pharmacy business — dispensing prescriptions, selling health and wellness products, and providing immunizations and clinical services — is the customer-facing foundation of a much larger healthcare enterprise that includes pharmacy benefit management and health insurance.\n\nCVS Pharmacy is the consumer brand within the broader CVS Health corporation, which also operates Caremark (one of the largest pharmacy benefit managers in the US, processing hundreds of millions of prescriptions annually) and Aetna (a major health insurer with tens of millions of members). This integration of retail pharmacy, PBM, and health insurance makes CVS Health one of the most vertically integrated healthcare companies in the world, with levers spanning drug dispensing, formulary management, and member health management across the full care continuum. CVS has also expanded into primary care through its MinuteClinics and the acquisition of Oak Street Health.\n\nIn 2026, CVS Pharmacy is actively expanding its pharmacy-only format — smaller footprint locations focused exclusively on prescription fulfillment and clinical pharmacy services, rather than the traditional front-end retail merchandise mix. This format evolution reflects a strategic pivot toward healthcare services as retail foot traffic shifts to e-commerce. CVS Health reported approximately $372B in total revenue, reflecting its scale across all business segments. The company faces ongoing margin pressure from drug pricing dynamics and PBM reform discussions, but its integrated model and massive national footprint make it a structurally important player in US healthcare delivery.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.